SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-144463
Filing Date
2021-11-29
Accepted
2021-11-29 16:30:45
Documents
14
Period of Report
2021-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134066d1_8k.htm   iXBRL 8-K 25542
2 EXHIBIT 10.1 tm2134066d1_ex10-1.htm EX-10.1 24367
6 GRAPHIC tm2134066d1_ex10-1img001.jpg GRAPHIC 5825
  Complete submission text file 0001104659-21-144463.txt   236427

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nviv-20211123.xsd EX-101.SCH 3055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20211123_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20211123_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2134066d1_8k_htm.xml XML 3620
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 211456596
SIC: 3841 Surgical & Medical Instruments & Apparatus